Is There a Rationale for GnRH Analogue Therapy in Endometriosis?

In: GnRH Analogues in Cancer and Human Reproduction · 1990 · pp. 1–6 · doi:10.1007/978-94-009-2169-6_1 · W4248824220
book-chapter OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
AI-generated summary by claude@2026-06+body, 2026-06-08

This paper discusses the diagnostic criteria and evaluation of medical therapy response for endometriosis, a common gynecological disease with persistent controversies in its pathogenesis and pathophysiology.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-09

This chapter discusses diagnostic criteria for endometriosis and how response to medical therapy should be evaluated, with the overarching aim of examining whether there is a rationale for GnRH analogue therapy. It frames endometriosis within broader controversies about its pathogenesis and pathophysiology, drawing on existing evidence and background research rather than presenting a new original patient study. A major caveat is that the work is largely conceptual and review-based, relying on criteria and prior studies without providing new controlled comparative outcome data. Relevance to endometriosis: the entire chapter is specifically about endometriosis and evaluates the rationale for GnRH analogue therapy within the context of diagnostic and treatment response assessment, so it is directly focused on endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (13)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK